carbamates has been researched along with Drug Abuse, Intravenous in 8 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " We evaluated non-adherence (<90% adherent) as measured by electronic blister-pack assessed using logistic regression and generalised estimating equations (continuous) with detailed analyses of dosing dynamics." | 2.87 | Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use: The SIMPLIFY study. ( Amin, J; Applegate, TL; Bruggmann, P; Bruneau, J; Conway, B; Cooper, C; Cunningham, EB; Dalgard, O; Dillon, JF; Dore, GJ; Dunlop, AJ; Feld, JJ; Fraser, C; Gane, E; Grebely, J; Hajarizadeh, B; Hellard, M; Litwin, AH; Marks, P; Matthews, GV; Norton, B; Powis, J; Quiene, S; Read, P; Shaw, D; Siriragavan, S; Thurnheer, MC; Weltman, M, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rahman, M | 1 |
| Janjua, NZ | 1 |
| Shafiq, TKI | 1 |
| Chowdhury, EI | 1 |
| Sarker, MS | 1 |
| Khan, SI | 1 |
| Reza, M | 1 |
| Faruque, MO | 1 |
| Kabir, A | 1 |
| Anis, AH | 1 |
| Azim, T | 1 |
| Bielen, R | 1 |
| Moreno, C | 1 |
| Van Vlierberghe, H | 1 |
| Bourgeois, S | 1 |
| Mulkay, JP | 1 |
| Vanwolleghem, T | 1 |
| Verlinden, W | 1 |
| Brixko, C | 1 |
| Decaestecker, J | 1 |
| De Galocsy, C | 1 |
| Janssens, F | 1 |
| Cool, M | 1 |
| Van Overbeke, L | 1 |
| Van Steenkiste, C | 1 |
| D'heygere, F | 1 |
| Cools, W | 1 |
| Nevens, F | 1 |
| Robaeys, G | 1 |
| Grebely, J | 4 |
| Dalgard, O | 3 |
| Conway, B | 3 |
| Cunningham, EB | 3 |
| Bruggmann, P | 3 |
| Hajarizadeh, B | 4 |
| Amin, J | 2 |
| Bruneau, J | 3 |
| Hellard, M | 3 |
| Litwin, AH | 2 |
| Marks, P | 3 |
| Quiene, S | 2 |
| Siriragavan, S | 2 |
| Applegate, TL | 3 |
| Swan, T | 1 |
| Byrne, J | 1 |
| Lacalamita, M | 1 |
| Dunlop, A | 2 |
| Matthews, GV | 3 |
| Powis, J | 3 |
| Shaw, D | 3 |
| Thurnheer, MC | 2 |
| Weltman, M | 2 |
| Kronborg, I | 2 |
| Cooper, C | 3 |
| Feld, JJ | 3 |
| Fraser, C | 3 |
| Dillon, JF | 2 |
| Read, P | 2 |
| Gane, E | 3 |
| Dore, GJ | 4 |
| Dunlop, AJ | 1 |
| Norton, B | 1 |
| Moriggia, A | 1 |
| Stedman, C | 1 |
| Castro, E | 1 |
| Schmid, P | 1 |
| Petoumenos, K | 1 |
| Erratt, A | 1 |
| Lacombe, K | 1 |
| Daulouede, JP | 1 |
| Crawford, S | 1 |
| Alavi, M | 1 |
| Poustchi, H | 1 |
| Merat, S | 1 |
| Kaveh-Ei, S | 1 |
| Rahimi-Movaghar, A | 1 |
| Shadloo, B | 1 |
| Malekzadeh, R | 1 |
| Warparkowski, A | 1 |
| Seifert, LL | 1 |
| Heinzow, H | 1 |
| Kabar, I | 1 |
| Christensen, S | 1 |
| Hüsing, A | 1 |
| Schmidt, HH | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase II, Open-label, Single Arm, Multicentre, International Trial of Sofosbuvir (SOF) and GS-5816 for People With Chronic Hepatitis C Virus Infection and Recent Injection Drug Use[NCT02336139] | Phase 2 | 103 participants (Actual) | Interventional | 2016-03-16 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 trials available for carbamates and Drug Abuse, Intravenous
| Article | Year |
|---|---|
Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial.
Topics: Administration, Oral; Adult; Antiviral Agents; Carbamates; Drug Administration Schedule; Drug Packag | 2018 |
Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use: The SIMPLIFY study.
Topics: Adult; Antiviral Agents; Carbamates; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Hetero | 2018 |
An intervention to improve HCV testing, linkage to care, and treatment among people who use drugs in Tehran, Iran: The ENHANCE study.
Topics: Adult; Antiviral Agents; Carbamates; Drug Combinations; Female; Hepatitis C; Hepatitis C Antibodies; | 2019 |
[High chance of healing for opiate dependent patients].
Topics: Amides; Benzofurans; Carbamates; Cyclopropanes; Double-Blind Method; Drug Combinations; Hepatitis C, | 2016 |
4 other studies available for carbamates and Drug Abuse, Intravenous
| Article | Year |
|---|---|
Hepatitis C virus treatment in people who inject drugs (PWID) in Bangladesh.
Topics: Adult; Aged; Antiviral Agents; Bangladesh; Carbamates; Drug Therapy, Combination; Female; Follow-Up | 2019 |
Belgian experience with direct acting antivirals in people who inject drugs.
Topics: Adult; Aged; Antiviral Agents; Belgium; Carbamates; Cohort Studies; Female; Hepacivirus; Hepatitis C | 2017 |
Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people with HCV genotype 1 and recent injecting drug use or receiving opioid substitution therapy.
Topics: 2-Naphthylamine; Adult; Anilides; Antiviral Agents; Carbamates; Cyclopropanes; Drug Administration S | 2018 |
Successful Anti-HCV Therapy of a Former Intravenous Drug User with Sofosbuvir and Daclatasvir in a Peritranspant Setting: A Case Report.
Topics: Adult; Antiviral Agents; Carbamates; Hepatitis C, Chronic; Humans; Imidazoles; Liver Transplantation | 2016 |